| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |